Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Osada

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Journal of Translational Medicine|February 14, 2012
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected]Erika Hamilton, Kimberly Blackwell, Amy C Hobeika, et al.
Journal for Immunotherapy of Cancer|April 1, 2022
Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpressionBin-Jin Hwang, Li-Chung Tsao, Chaitanya R Acharya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.
Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Communications Biology|May 10, 2020
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumorsKensuke Kaneko, Takuya Osada, Michael A Morse, et al.
Molecular Cancer Therapeutics|February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancerMickey K Kim, Takuya Osada, William T Barry, et al.
Journal for Immunotherapy of Cancer|January 18, 2022
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunityShinya Abe, Hiroshi Nagata, Erika J Crosby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patientsMichael A Morse, Robert Chapman, John Powderly, et al.
Breast Cancer Research : BCR|June 9, 2012
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cellsXiu-Rong Ren, Junping Wei, Gangjun Lei, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Journal of Translational Medicine|February 14, 2012
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected]Erika Hamilton, Kimberly Blackwell, Amy C Hobeika, et al.
Journal for Immunotherapy of Cancer|April 1, 2022
Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpressionBin-Jin Hwang, Li-Chung Tsao, Chaitanya R Acharya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.
Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Communications Biology|May 10, 2020
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumorsKensuke Kaneko, Takuya Osada, Michael A Morse, et al.
Molecular Cancer Therapeutics|February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancerMickey K Kim, Takuya Osada, William T Barry, et al.
Journal for Immunotherapy of Cancer|January 18, 2022
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunityShinya Abe, Hiroshi Nagata, Erika J Crosby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patientsMichael A Morse, Robert Chapman, John Powderly, et al.
Breast Cancer Research : BCR|June 9, 2012
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cellsXiu-Rong Ren, Junping Wei, Gangjun Lei, et al.
Pageof 14